Grifols GRFS
NASDAQ GRFS
$8.00 +0.01 (+0.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Grifols (GRFS) Sales of Property, Plant and Equipment (2010 - 2016)

Grifols (GRFS) Sales of Property, Plant and Equipment (2010 - 2016) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn 63.00 Mn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn -
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 26.00 Mn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn 4.00 Mn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn -
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn -
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 4.03 Mn
10 Grifols 5.45 Bn 4.45 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2016 336,873.96
Dec 31, 2016 336,873.96
Sep 30, 2016 401,826.41
Sep 30, 2016 401,826.41
Dec 31, 2015 174,282.65
Dec 31, 2015 174,282.65
Sep 30, 2015 104,554.78
Sep 30, 2015 104,554.78
Jun 30, 2015 765,862.90
Jun 30, 2015 765,862.90
Mar 31, 2015 15.10 Mn
Mar 31, 2015 15.10 Mn
Dec 31, 2014 -18.04 Mn
Dec 31, 2014 -18.04 Mn
Sep 30, 2014 18.61 Mn
Sep 30, 2014 18.61 Mn
Jun 30, 2014 358,058.52
Jun 30, 2014 358,058.52
Mar 31, 2014 528,961.07
Mar 31, 2014 528,961.07